[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Toxicology Drug Screening Market 2022 by Company, Regions, Type and Application, Forecast to 2028

July 2022 | 110 pages | ID: GAF9E75A79C1EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Toxicology Drug Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Toxicology Drug Screening market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Toxicology Drug Screening global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cardiovascular Disease Drug Screening segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Toxicology Drug Screening include Thermo Fisher Scientific Inc., Merck, Bio-Rad Laboratories Inc., Danaher, and Charles River Laboratories International Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Toxicology Drug Screening market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
  • Cardiovascular Disease Drug Screening
  • Obesity Drug Screening
  • Diabetes Drug Screening
  • Others
Market segment by Application, can be divided into
  • Hospitals
  • Clinics
  • Laboratory
  • Others
Market segment by players, this report covers
  • Thermo Fisher Scientific Inc.
  • Merck
  • Bio-Rad Laboratories Inc.
  • Danaher
  • Charles River Laboratories International Inc.
  • Enzo Life Sciences Inc.
  • Eurofins Scientific
  • Selvita
  • Laboratory Corporation of America Holdings
  • Promega Corporation
  • The Jackson Laboratory
  • Agilent Technologies, Inc
  • Waters
  • TECHCOMP GROUP
  • Wuxi AppTec
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Toxicology Drug Screening product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Toxicology Drug Screening, with revenue, gross margin and global market share of Toxicology Drug Screening from 2019 to 2022.

Chapter 3, the Toxicology Drug Screening competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Toxicology Drug Screening market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Toxicology Drug Screening research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Toxicology Drug Screening
1.2 Classification of Toxicology Drug Screening by Type
  1.2.1 Overview: Global Toxicology Drug Screening Market Size by Type: 2017 Versus 2021 Versus 2028
  1.2.2 Global Toxicology Drug Screening Revenue Market Share by Type in 2021
  1.2.3 Cardiovascular Disease Drug Screening
  1.2.4 Obesity Drug Screening
  1.2.5 Diabetes Drug Screening
  1.2.6 Others
1.3 Global Toxicology Drug Screening Market by Application
  1.3.1 Overview: Global Toxicology Drug Screening Market Size by Application: 2017 Versus 2021 Versus 2028
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Laboratory
  1.3.5 Others
1.4 Global Toxicology Drug Screening Market Size & Forecast
1.5 Global Toxicology Drug Screening Market Size and Forecast by Region
  1.5.1 Global Toxicology Drug Screening Market Size by Region: 2017 VS 2021 VS 2028
  1.5.2 Global Toxicology Drug Screening Market Size by Region, (2017-2022)
  1.5.3 North America Toxicology Drug Screening Market Size and Prospect (2017-2028)
  1.5.4 Europe Toxicology Drug Screening Market Size and Prospect (2017-2028)
  1.5.5 Asia-Pacific Toxicology Drug Screening Market Size and Prospect (2017-2028)
  1.5.6 South America Toxicology Drug Screening Market Size and Prospect (2017-2028)
  1.5.7 Middle East and Africa Toxicology Drug Screening Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
  1.6.1 Toxicology Drug Screening Market Drivers
  1.6.2 Toxicology Drug Screening Market Restraints
  1.6.3 Toxicology Drug Screening Trends Analysis

2 COMPANY PROFILES

2.1 Thermo Fisher Scientific Inc.
  2.1.1 Thermo Fisher Scientific Inc. Details
  2.1.2 Thermo Fisher Scientific Inc. Major Business
  2.1.3 Thermo Fisher Scientific Inc. Toxicology Drug Screening Product and Solutions
  2.1.4 Thermo Fisher Scientific Inc. Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.1.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.2 Merck
  2.2.1 Merck Details
  2.2.2 Merck Major Business
  2.2.3 Merck Toxicology Drug Screening Product and Solutions
  2.2.4 Merck Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.2.5 Merck Recent Developments and Future Plans
2.3 Bio-Rad Laboratories Inc.
  2.3.1 Bio-Rad Laboratories Inc. Details
  2.3.2 Bio-Rad Laboratories Inc. Major Business
  2.3.3 Bio-Rad Laboratories Inc. Toxicology Drug Screening Product and Solutions
  2.3.4 Bio-Rad Laboratories Inc. Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.3.5 Bio-Rad Laboratories Inc. Recent Developments and Future Plans
2.4 Danaher
  2.4.1 Danaher Details
  2.4.2 Danaher Major Business
  2.4.3 Danaher Toxicology Drug Screening Product and Solutions
  2.4.4 Danaher Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.4.5 Danaher Recent Developments and Future Plans
2.5 Charles River Laboratories International Inc.
  2.5.1 Charles River Laboratories International Inc. Details
  2.5.2 Charles River Laboratories International Inc. Major Business
  2.5.3 Charles River Laboratories International Inc. Toxicology Drug Screening Product and Solutions
  2.5.4 Charles River Laboratories International Inc. Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.5.5 Charles River Laboratories International Inc. Recent Developments and Future Plans
2.6 Enzo Life Sciences Inc.
  2.6.1 Enzo Life Sciences Inc. Details
  2.6.2 Enzo Life Sciences Inc. Major Business
  2.6.3 Enzo Life Sciences Inc. Toxicology Drug Screening Product and Solutions
  2.6.4 Enzo Life Sciences Inc. Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.6.5 Enzo Life Sciences Inc. Recent Developments and Future Plans
2.7 Eurofins Scientific
  2.7.1 Eurofins Scientific Details
  2.7.2 Eurofins Scientific Major Business
  2.7.3 Eurofins Scientific Toxicology Drug Screening Product and Solutions
  2.7.4 Eurofins Scientific Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.7.5 Eurofins Scientific Recent Developments and Future Plans
2.8 Selvita
  2.8.1 Selvita Details
  2.8.2 Selvita Major Business
  2.8.3 Selvita Toxicology Drug Screening Product and Solutions
  2.8.4 Selvita Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.8.5 Selvita Recent Developments and Future Plans
2.9 Laboratory Corporation of America Holdings
  2.9.1 Laboratory Corporation of America Holdings Details
  2.9.2 Laboratory Corporation of America Holdings Major Business
  2.9.3 Laboratory Corporation of America Holdings Toxicology Drug Screening Product and Solutions
  2.9.4 Laboratory Corporation of America Holdings Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.9.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.10 Promega Corporation
  2.10.1 Promega Corporation Details
  2.10.2 Promega Corporation Major Business
  2.10.3 Promega Corporation Toxicology Drug Screening Product and Solutions
  2.10.4 Promega Corporation Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.10.5 Promega Corporation Recent Developments and Future Plans
2.11 The Jackson Laboratory
  2.11.1 The Jackson Laboratory Details
  2.11.2 The Jackson Laboratory Major Business
  2.11.3 The Jackson Laboratory Toxicology Drug Screening Product and Solutions
  2.11.4 The Jackson Laboratory Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.11.5 The Jackson Laboratory Recent Developments and Future Plans
2.12 Agilent Technologies, Inc
  2.12.1 Agilent Technologies, Inc Details
  2.12.2 Agilent Technologies, Inc Major Business
  2.12.3 Agilent Technologies, Inc Toxicology Drug Screening Product and Solutions
  2.12.4 Agilent Technologies, Inc Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.12.5 Agilent Technologies, Inc Recent Developments and Future Plans
2.13 Waters
  2.13.1 Waters Details
  2.13.2 Waters Major Business
  2.13.3 Waters Toxicology Drug Screening Product and Solutions
  2.13.4 Waters Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.13.5 Waters Recent Developments and Future Plans
2.14 TECHCOMP GROUP
  2.14.1 TECHCOMP GROUP Details
  2.14.2 TECHCOMP GROUP Major Business
  2.14.3 TECHCOMP GROUP Toxicology Drug Screening Product and Solutions
  2.14.4 TECHCOMP GROUP Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.14.5 TECHCOMP GROUP Recent Developments and Future Plans
2.15 Wuxi AppTec
  2.15.1 Wuxi AppTec Details
  2.15.2 Wuxi AppTec Major Business
  2.15.3 Wuxi AppTec Toxicology Drug Screening Product and Solutions
  2.15.4 Wuxi AppTec Toxicology Drug Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.15.5 Wuxi AppTec Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Toxicology Drug Screening Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
  3.2.1 Top 3 Toxicology Drug Screening Players Market Share in 2021
  3.2.2 Top 10 Toxicology Drug Screening Players Market Share in 2021
  3.2.3 Market Competition Trend
3.3 Toxicology Drug Screening Players Head Office, Products and Services Provided
3.4 Toxicology Drug Screening Mergers & Acquisitions
3.5 Toxicology Drug Screening New Entrants and Expansion Plans

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Toxicology Drug Screening Revenue and Market Share by Type (2017-2022)
4.2 Global Toxicology Drug Screening Market Forecast by Type (2023-2028)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Toxicology Drug Screening Revenue Market Share by Application (2017-2022)
5.2 Global Toxicology Drug Screening Market Forecast by Application (2023-2028)

6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

6.1 North America Toxicology Drug Screening Revenue by Type (2017-2028)
6.2 North America Toxicology Drug Screening Revenue by Application (2017-2028)
6.3 North America Toxicology Drug Screening Market Size by Country
  6.3.1 North America Toxicology Drug Screening Revenue by Country (2017-2028)
  6.3.2 United States Toxicology Drug Screening Market Size and Forecast (2017-2028)
  6.3.3 Canada Toxicology Drug Screening Market Size and Forecast (2017-2028)
  6.3.4 Mexico Toxicology Drug Screening Market Size and Forecast (2017-2028)

7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 Europe Toxicology Drug Screening Revenue by Type (2017-2028)
7.2 Europe Toxicology Drug Screening Revenue by Application (2017-2028)
7.3 Europe Toxicology Drug Screening Market Size by Country
  7.3.1 Europe Toxicology Drug Screening Revenue by Country (2017-2028)
  7.3.2 Germany Toxicology Drug Screening Market Size and Forecast (2017-2028)
  7.3.3 France Toxicology Drug Screening Market Size and Forecast (2017-2028)
  7.3.4 United Kingdom Toxicology Drug Screening Market Size and Forecast (2017-2028)
  7.3.5 Russia Toxicology Drug Screening Market Size and Forecast (2017-2028)
  7.3.6 Italy Toxicology Drug Screening Market Size and Forecast (2017-2028)

8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION

8.1 Asia-Pacific Toxicology Drug Screening Revenue by Type (2017-2028)
8.2 Asia-Pacific Toxicology Drug Screening Revenue by Application (2017-2028)
8.3 Asia-Pacific Toxicology Drug Screening Market Size by Region
  8.3.1 Asia-Pacific Toxicology Drug Screening Revenue by Region (2017-2028)
  8.3.2 China Toxicology Drug Screening Market Size and Forecast (2017-2028)
  8.3.3 Japan Toxicology Drug Screening Market Size and Forecast (2017-2028)
  8.3.4 South Korea Toxicology Drug Screening Market Size and Forecast (2017-2028)
  8.3.5 India Toxicology Drug Screening Market Size and Forecast (2017-2028)
  8.3.6 Southeast Asia Toxicology Drug Screening Market Size and Forecast (2017-2028)
  8.3.7 Australia Toxicology Drug Screening Market Size and Forecast (2017-2028)

9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

9.1 South America Toxicology Drug Screening Revenue by Type (2017-2028)
9.2 South America Toxicology Drug Screening Revenue by Application (2017-2028)
9.3 South America Toxicology Drug Screening Market Size by Country
  9.3.1 South America Toxicology Drug Screening Revenue by Country (2017-2028)
  9.3.2 Brazil Toxicology Drug Screening Market Size and Forecast (2017-2028)
  9.3.3 Argentina Toxicology Drug Screening Market Size and Forecast (2017-2028)

10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

10.1 Middle East & Africa Toxicology Drug Screening Revenue by Type (2017-2028)
10.2 Middle East & Africa Toxicology Drug Screening Revenue by Application (2017-2028)
10.3 Middle East & Africa Toxicology Drug Screening Market Size by Country
  10.3.1 Middle East & Africa Toxicology Drug Screening Revenue by Country (2017-2028)
  10.3.2 Turkey Toxicology Drug Screening Market Size and Forecast (2017-2028)
  10.3.3 Saudi Arabia Toxicology Drug Screening Market Size and Forecast (2017-2028)
  10.3.4 UAE Toxicology Drug Screening Market Size and Forecast (2017-2028)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

LIST OF TABLES

Table 1. Global Toxicology Drug Screening Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Toxicology Drug Screening Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Toxicology Drug Screening Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Toxicology Drug Screening Revenue (USD Million) by Region (2017-2022)
Table 5. Global Toxicology Drug Screening Revenue Market Share by Region (2023-2028)
Table 6. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Inc. Major Business
Table 8. Thermo Fisher Scientific Inc. Toxicology Drug Screening Product and Solutions
Table 9. Thermo Fisher Scientific Inc. Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Toxicology Drug Screening Product and Solutions
Table 13. Merck Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bio-Rad Laboratories Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Bio-Rad Laboratories Inc. Major Business
Table 16. Bio-Rad Laboratories Inc. Toxicology Drug Screening Product and Solutions
Table 17. Bio-Rad Laboratories Inc. Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Danaher Corporate Information, Head Office, and Major Competitors
Table 19. Danaher Major Business
Table 20. Danaher Toxicology Drug Screening Product and Solutions
Table 21. Danaher Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Charles River Laboratories International Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Charles River Laboratories International Inc. Major Business
Table 24. Charles River Laboratories International Inc. Toxicology Drug Screening Product and Solutions
Table 25. Charles River Laboratories International Inc. Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Enzo Life Sciences Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Enzo Life Sciences Inc. Major Business
Table 28. Enzo Life Sciences Inc. Toxicology Drug Screening Product and Solutions
Table 29. Enzo Life Sciences Inc. Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 31. Eurofins Scientific Major Business
Table 32. Eurofins Scientific Toxicology Drug Screening Product and Solutions
Table 33. Eurofins Scientific Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Selvita Corporate Information, Head Office, and Major Competitors
Table 35. Selvita Major Business
Table 36. Selvita Toxicology Drug Screening Product and Solutions
Table 37. Selvita Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Laboratory Corporation of America Holdings Corporate Information, Head Office, and Major Competitors
Table 39. Laboratory Corporation of America Holdings Major Business
Table 40. Laboratory Corporation of America Holdings Toxicology Drug Screening Product and Solutions
Table 41. Laboratory Corporation of America Holdings Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Promega Corporation Corporate Information, Head Office, and Major Competitors
Table 43. Promega Corporation Major Business
Table 44. Promega Corporation Toxicology Drug Screening Product and Solutions
Table 45. Promega Corporation Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. The Jackson Laboratory Corporate Information, Head Office, and Major Competitors
Table 47. The Jackson Laboratory Major Business
Table 48. The Jackson Laboratory Toxicology Drug Screening Product and Solutions
Table 49. The Jackson Laboratory Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Agilent Technologies, Inc Corporate Information, Head Office, and Major Competitors
Table 51. Agilent Technologies, Inc Major Business
Table 52. Agilent Technologies, Inc Toxicology Drug Screening Product and Solutions
Table 53. Agilent Technologies, Inc Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Waters Corporate Information, Head Office, and Major Competitors
Table 55. Waters Major Business
Table 56. Waters Toxicology Drug Screening Product and Solutions
Table 57. Waters Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. TECHCOMP GROUP Corporate Information, Head Office, and Major Competitors
Table 59. TECHCOMP GROUP Major Business
Table 60. TECHCOMP GROUP Toxicology Drug Screening Product and Solutions
Table 61. TECHCOMP GROUP Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Wuxi AppTec Corporate Information, Head Office, and Major Competitors
Table 63. Wuxi AppTec Major Business
Table 64. Wuxi AppTec Toxicology Drug Screening Product and Solutions
Table 65. Wuxi AppTec Toxicology Drug Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Toxicology Drug Screening Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Toxicology Drug Screening Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Toxicology Drug Screening by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Toxicology Drug Screening Players Head Office, Products and Services Provided
Table 70. Toxicology Drug Screening Mergers & Acquisitions in the Past Five Years
Table 71. Toxicology Drug Screening New Entrants and Expansion Plans
Table 72. Global Toxicology Drug Screening Revenue (USD Million) by Type (2017-2022)
Table 73. Global Toxicology Drug Screening Revenue Share by Type (2017-2022)
Table 74. Global Toxicology Drug Screening Revenue Forecast by Type (2023-2028)
Table 75. Global Toxicology Drug Screening Revenue by Application (2017-2022)
Table 76. Global Toxicology Drug Screening Revenue Forecast by Application (2023-2028)
Table 77. North America Toxicology Drug Screening Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Toxicology Drug Screening Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Toxicology Drug Screening Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Toxicology Drug Screening Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Toxicology Drug Screening Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Toxicology Drug Screening Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Toxicology Drug Screening Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Toxicology Drug Screening Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Toxicology Drug Screening Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Toxicology Drug Screening Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Toxicology Drug Screening Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Toxicology Drug Screening Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Toxicology Drug Screening Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Toxicology Drug Screening Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Toxicology Drug Screening Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Toxicology Drug Screening Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Toxicology Drug Screening Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Toxicology Drug Screening Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Toxicology Drug Screening Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Toxicology Drug Screening Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Toxicology Drug Screening Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Toxicology Drug Screening Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Toxicology Drug Screening Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Toxicology Drug Screening Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Toxicology Drug Screening Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Toxicology Drug Screening Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Toxicology Drug Screening Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Toxicology Drug Screening Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Toxicology Drug Screening Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Toxicology Drug Screening Revenue by Country (2023-2028) & (USD Million)

LIST OF FIGURES

Figure 1. Toxicology Drug Screening Picture
Figure 2. Global Toxicology Drug Screening Revenue Market Share by Type in 2021
Figure 3. Cardiovascular Disease Drug Screening
Figure 4. Obesity Drug Screening
Figure 5. Diabetes Drug Screening
Figure 6. Others
Figure 7. Toxicology Drug Screening Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Laboratory Picture
Figure 11. Others Picture
Figure 12. Global Toxicology Drug Screening Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Toxicology Drug Screening Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Toxicology Drug Screening Revenue Market Share by Region (2017-2028)
Figure 15. Global Toxicology Drug Screening Revenue Market Share by Region in 2021
Figure 16. North America Toxicology Drug Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Toxicology Drug Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Toxicology Drug Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Toxicology Drug Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Toxicology Drug Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Toxicology Drug Screening Market Drivers
Figure 22. Toxicology Drug Screening Market Restraints
Figure 23. Toxicology Drug Screening Market Trends
Figure 24. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Figure 25. Merck Recent Developments and Future Plans
Figure 26. Bio-Rad Laboratories Inc. Recent Developments and Future Plans
Figure 27. Danaher Recent Developments and Future Plans
Figure 28. Charles River Laboratories International Inc. Recent Developments and Future Plans
Figure 29. Enzo Life Sciences Inc. Recent Developments and Future Plans
Figure 30. Eurofins Scientific Recent Developments and Future Plans
Figure 31. Selvita Recent Developments and Future Plans
Figure 32. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Figure 33. Promega Corporation Recent Developments and Future Plans
Figure 34. The Jackson Laboratory Recent Developments and Future Plans
Figure 35. Agilent Technologies, Inc Recent Developments and Future Plans
Figure 36. Waters Recent Developments and Future Plans
Figure 37. TECHCOMP GROUP Recent Developments and Future Plans
Figure 38. Wuxi AppTec Recent Developments and Future Plans
Figure 39. Global Toxicology Drug Screening Revenue Share by Players in 2021
Figure 40. Toxicology Drug Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Toxicology Drug Screening Revenue Market Share in 2021
Figure 42. Global Top 10 Players Toxicology Drug Screening Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Toxicology Drug Screening Revenue Share by Type in 2021
Figure 45. Global Toxicology Drug Screening Market Share Forecast by Type (2023-2028)
Figure 46. Global Toxicology Drug Screening Revenue Share by Application in 2021
Figure 47. Global Toxicology Drug Screening Market Share Forecast by Application (2023-2028)
Figure 48. North America Toxicology Drug Screening Sales Market Share by Type (2017-2028)
Figure 49. North America Toxicology Drug Screening Sales Market Share by Application (2017-2028)
Figure 50. North America Toxicology Drug Screening Revenue Market Share by Country (2017-2028)
Figure 51. United States Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Toxicology Drug Screening Sales Market Share by Type (2017-2028)
Figure 55. Europe Toxicology Drug Screening Sales Market Share by Application (2017-2028)
Figure 56. Europe Toxicology Drug Screening Revenue Market Share by Country (2017-2028)
Figure 57. Germany Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Toxicology Drug Screening Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific Toxicology Drug Screening Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Toxicology Drug Screening Revenue Market Share by Region (2017-2028)
Figure 65. China Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Toxicology Drug Screening Sales Market Share by Type (2017-2028)
Figure 72. South America Toxicology Drug Screening Sales Market Share by Application (2017-2028)
Figure 73. South America Toxicology Drug Screening Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Toxicology Drug Screening Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Toxicology Drug Screening Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Toxicology Drug Screening Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Toxicology Drug Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source


More Publications